Incyte Corporation

This study tested an experimental drug called povorcitinib in 136 adults with chronic spontaneous urticaria (hives) that standard treatments couldn't control. The goal was to see if the drug could reduce itching and hives over 12 weeks. Participants continued their usual antihist…

This study tested whether adding the immunotherapy drug INCMGA00012 to standard chemotherapy (carboplatin-paclitaxel) helps people with advanced anal cancer that cannot be removed by surgery. The trial included 308 adults who had not received chemotherapy for this condition. Rese…

This study tested a cream called ruxolitinib on 49 people with genital vitiligo, a condition that causes white patches on the genitals. Participants applied the cream twice a day for up to 48 weeks to see if it made the patches less noticeable. The goal was to find out if the cre…

This study tested a new drug called povorcitinib in 608 adults with moderate to severe hidradenitis suppurativa (HS), a painful skin condition that causes boils and tunnels under the skin. For the first 12 weeks, some participants received the drug and others received a placebo, …

This study tested whether adding epacadostat to pembrolizumab (an immunotherapy) works better than pembrolizumab alone or standard chemotherapy for people with advanced head and neck cancer that has come back or spread. The trial enrolled 89 adults whose cancer could be measured …

This study looked at how a single dose of the drug INCB099280 is absorbed, broken down, and removed from the body. Five healthy men took one pill, and researchers measured the drug and its byproducts in their blood, urine, and stool. The goal was to understand the drug's journey,…